Singapore

SUTD researchers designed a novel nonlinear chiral metasurface that could generate circularly polarized light more easily, expanding optics-based applications.

• The legacy of Duke-NUS’ founding donor, the Estate of Khoo Teck Puat, continues with a transformative S$5.5 million gift towards research. • The HEAD Foundation steps up with a S$200,000 scholarship, underpinning Duke-NUS’ commitment to developing medical expertise.

Duke-NUS study findings challenge the longstanding reliance on neutralising antibodies for assessing viral immunity, and suggest that development of future vaccines must consider both antibody and T-cell responses for comprehensive protection.

Duke-NUS researchers have discovered that foetuses can manage their own immune responses to combat diseases and infections like Zika

An SUTD researcher has developed a promising automated workflow that leverages a large language model to generate a design structure matrix in less than five minutes.

SUTD researchers developed a novel bilayer metasurface that enables unidirectional circularly polarised waves to be emitted, opening up possibilities in the fields of biological and chemical sensing, optical communications, and quantum computing.

• This breakthrough test requires only a small blood sample to track modified T cells in patients over time, ensuring therapies remain effective. • This plug-and-play approach is set to accelerate the development of more T-cell-based therapies and vaccines.

Duke-NUS scientists investigated how an inherited genetic variation common among East Asians contributes to drug resistance in cancer cells, driving more aggressive cancer growth. The team trialled a precision therapy for this group by blocking the action of a protein called MCL-1, successfully killing many of the cancer cells in laboratory studies.

28 October 2024, Singapore – EDUtech Asia 2024, will be back for its 9th edition from 6 to 7 November. Organised by Terrapinn, EDUtech Asia 2024 will offer a distinguished lineup of education leaders, decision-makers, policy makers, educators, innovators and disruptors to collaborate and reimagine the future of education with the power of tech.

Organised by IPI, a subsidiary of Enterprise Singapore, this flagship event serves as an essential platform for businesses to explore growth opportunities through strategic matchmaking with industry leaders and potential partners.

An international team of neuroscientists showed for the first time that modifying a protein that controls cell growth can reactivate dormant neural stem cells in fruit flies, offering new hope in the fight against neurological diseases.

To enhance the life quality of patients with sleep disordered breathing, researchers and clinicians led by an SUTD scientist used computational modelling to design custom-fit masks that have improved positive airway pressure treatment.

A team of scientists in Singapore and the US uncovered how a protein that controls our biological clock modifies its own function, offering new ways for treating jet lag and seasonal adjustments

Duke-NUS introduces 35 innovative pictograms to make medication instructions clearer, especially for seniors.

Scientists have discovered that blocking the activity of the hormone glucagon could treat a common and challenging type of heart failure that affects millions worldwide.

Scientists identified a protein that regulates cellular clean-up, could also hold the key to new treatments for age-related muscle loss and muscle wasting in cancer patients, enhancing quality of life.

• Two-year assessment provides critical insights and recommendations for strengthening genomic sequencing for infectious disease surveillance in 13 South and Southeast Asian countries. • Research helps to step up Asia’s preparedness across wide range of diseases.

A Duke-NUS Medical School-led study highlights the role of natural killer T cells in influencing the immune response to dengue virus, potentially reducing the severity of subsequent infections.

An international consortium led by Duke-NUS Medical School introduces an ethics checklist for systematic and standardised assessment for research involving generative AI technologies in healthcare settings, enhancing accountability

TechInnovation 2024, IPI Singapore’s flagship event, is set to return this year from 28 - 30 October at Marina Bay Sands, Level 4, Roselle-Simpor Ballroom, as a premier event dedicated to exploring Sustainable Urban Living.

The surprising discovery that cellular protein Gα13 may actually protect against—rather than promote growth of—the most commonly relapsing type of breast cancer signals potential for more effective and innovative treatments.

This alliance by the student bodies of Singapore’s three medical schools continues to unify and represent the voice of the local medical student community through regular dialogue, engagement and collaboration with external stakeholders, including the Singapore Medical Association and Ministry of Health.

It is the first study to estimate informal caregiving time and its monetary value in Singapore in the context of seniors requiring day-to-day care. Study findings highlight the need to acknowledge the contributions of informal caregivers—family members or friends providing unpaid help to seniors for their daily living activities.

SUTD researchers developed a new method of producing metallic structures at room temperature and pressure using the same process that insects and lobsters use to create their shells, unlocking a new type of energy-efficient metalworking.

Collaborative study by Duke-NUS and NUS Mechanobiology Institute offers new hope for treating neurodevelopmental disorders by activating dormant neural stem cells and uncovering other mechanisms behind brain development.

A violinist, an athlete, engineers and architecture graduates highlight the diversity and drive of Duke-NUS Medical School’s 18th cohort of medical students.

A randomised trial conducted by health economists at Duke-NUS Medical School found that a bit of peer influence can nudge us to select healthier groceries.

- Recipient Associate Professor Lena Ho spearheads groundbreaking research to develop first- in-class therapeutics to target inflammatory diseases; Collaboration between 65LAB and Duke-NUS aims to advance promising innovation from academic institutions with potential to build new therapeutic companies from Singapore; S$1.85 million funding comprises US$1.5 million from 65LAB and US$350,000 from Duke- NUS' newly established incubator, LIVE Ventures

Duke-NUS Medical School today launched LIVE Ventures, a S$20 million incubation programme designed to catalyse the commercialisation of innovative academic research. Focused on translating scientific breakthroughs into clinical applications, LIVE Ventures will provide Duke-NUS scientists conducting high-impact research with essential commercialisation expertise and resources and partner with both public and private sector entities to co-fund these projects.

A study from Duke-NUS Medical School and the NUS Yong Loo Lin School of Medicine (NUS Medicine) estimates that the yearly additional costs of about S$700 per person are mainly due to emergency and subsequent hospital admissions. In total, these costs are set to rise to S$106 million annually in 2030 as the population ages.